Evaluation of Fibroblast Activation Protein-Alpha (FAP) as a Diagnostic Marker and Therapeutic Target in Prostate Cancer

2007 ◽  
Author(s):  
Nathaniel Brennen
2021 ◽  
Vol 181 ◽  
pp. 105833
Author(s):  
Cecy R. Xi ◽  
Arianna Di Fazio ◽  
Naveed Ahmed Nadvi ◽  
Michelle Sui Wen Xiang ◽  
Hui Emma Zhang ◽  
...  

The Prostate ◽  
2017 ◽  
Vol 77 (15) ◽  
pp. 1499-1511 ◽  
Author(s):  
Sergio Pedraza-Arévalo ◽  
Daniel Hormaechea-Agulla ◽  
Enrique Gómez-Gómez ◽  
María J. Requena ◽  
Luke A. Selth ◽  
...  

Immunotherapy ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 155-175
Author(s):  
W Nathaniel Brennen ◽  
Daniel L J Thorek ◽  
Wen Jiang ◽  
Timothy E Krueger ◽  
Lizamma Antony ◽  
...  

The tumor microenvironment contributes to disease progression through multiple mechanisms, including immune suppression mediated in part by fibroblast activation protein (FAP)-expressing cells. Herein, a review of FAP biology is presented, supplemented with primary data. This includes FAP expression in prostate cancer and activation of latent reservoirs of TGF-β and VEGF to produce a positive feedback loop. This collectively suggests a normal wound repair process subverted during cancer pathophysiology. There has been immense interest in targeting FAP for diagnostic, monitoring and therapeutic purposes. Until recently, this development has outpaced an understanding of the biology; impeding optimal translation into the clinic. A summary of these applications is provided with an emphasis on eliminating tumor-infiltrating FAP-positive cells to overcome stromal barriers to immuno-oncological responses.


2018 ◽  
Vol 83 (4) ◽  
pp. 381-387 ◽  
Author(s):  
Ana Carolinne da Silva ◽  
Millena Prata Jammal ◽  
Renata Margarida Etchebehere ◽  
Eddie Fernando Candido Murta ◽  
Rosekeila Simões Nomelini

Sign in / Sign up

Export Citation Format

Share Document